Related Experiment Video

Updated: Aug 19, 2026

A Pre-Clinical Model of Synovitis Using Ex vivo Human Synovial Tissue with Preserved Function and Architecture
08:32

A Pre-Clinical Model of Synovitis Using Ex vivo Human Synovial Tissue with Preserved Function and Architecture

Published on: March 20, 2026

[Mechanisms of joint destruction in rheumatoid arthritis]

Satoshi Sohen1

  • 1Department of Orthopaedic Surgery, Nara Hospital, Kinki University School of Medicine.

Clinical Calcium
|March 19, 2005
PubMed

Insights

Pannus secretes destructive enzymes like matrix metalloproteinases (MMPs) and cathepsins that degrade articular cartilage. Cytokines and osteoclast differentiation factor (ODF) also contribute to cartilage and bone destruction in joints.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Rheumatology

Context:

  • Pannus formation is a hallmark of inflammatory joint diseases.
  • Articular cartilage and subchondral bone are key structures affected by joint destruction.

Purpose:

  • To identify and describe the key molecular mediators involved in joint degradation.
  • To elucidate the mechanisms by which pannus contributes to cartilage and bone resorption.

Summary:

  • Pannus tissue secretes destructive enzymes, including matrix metalloproteinases (MMPs) and cathepsins, which degrade the collagen and proteoglycan matrix of articular cartilage.
  • Pro-inflammatory cytokines such as TNF-alpha and IL-1, along with osteoclast differentiation factor (ODF) (also known as RANKL), stimulate osteoclast activity, leading to subchondral bone resorption.

Impact:

  • Understanding these destructive pathways is crucial for developing targeted therapies for joint diseases.
  • Identifying specific enzymes and signaling molecules offers potential targets for inhibiting cartilage and bone erosion.

Related Concept Videos

Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...